


Ask a doctor about a prescription for METOCLOPRAMIDE ACCORD 10 mg TABLETS
Package Leaflet: Information for the User
Metoclopramide Accord 10 mg Tablets EFG
Metoclopramide Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Metoclopramide Accord is an antiemetic. It contains a medicine called metoclopramide. It works in a part of the brain that prevents nausea and vomiting.
Adult population:
Metoclopramide is indicated in adults:
Metoclopramide can be taken in combination with oral analgesics in the case of migraine to make the analgesics more effective.
Paediatric population
Metoclopramide is indicated in children (from 1 to 18 years of age) if other treatments do not work or cannot be used to prevent nausea and vomiting that may occur after chemotherapy.
Do not take Metoclopramide Accord:
Do not give Metoclopramide Accord to children under 1 year of age (see below "Children and adolescents").
Do not take Metoclopramide Accord if any of the above applies to you. If you are not sure, consult your doctor, pharmacist or nurse before taking Metoclopramide Accord.
Warnings and precautions
Consult your doctor or pharmacist before starting Metoclopramide Accord if:
Your doctor may perform blood tests to check your blood pigment levels. In cases of abnormal levels (methaemoglobinemia), treatment should be stopped immediately and permanently.
You should wait at least 6 hours between each dose of metoclopramide, even in case of vomiting and rejection of the dose, to avoid overdose.
Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults.
This medicine should not be used in children under 1 year of age due to the high risk of uncontrollable movements (see above "Do not take Metoclopramide Accord if").
Using Metoclopramide Accord with other medicines
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This is because some medicines may affect the way Metoclopramide Accord works or Metoclopramide Accord may affect the way other medicines work. These medicines include:
Using Metoclopramide Accord with alcohol
Do not drink alcohol while being treated with metoclopramide because it increases the sedative effect of Metoclopramide Accord.
Pregnancy, breast-feeding and fertility
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Metoclopramide Accord may be taken during pregnancy if necessary. Your doctor will decide whether you can be given this medicine or not.
Metoclopramide Accord is not recommended if you are breast-feeding because metoclopramide passes into breast milk and may affect your baby.
Driving and using machines
After taking Metoclopramide Accord, you may feel drowsy, dizzy or have uncontrollable movements of tics, twitches or torsion and muscle tone that causes distortion of your body. This may affect your vision and also interfere with your ability to drive and use machines.
Metoclopramide Accord contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Adult population:
A single dose of 10 mg is recommended, which can be repeated up to three times a day.
The maximum recommended daily dose is 30 mg or 0.5 mg/kg body weight.
The maximum duration of treatment is 5 days.
To prevent delayed nausea and vomiting that may occur after chemotherapy (children from 1 to 18 years of age)
The recommended dose is 0.1 to 0.15 mg/kg body weight, which can be repeated up to a maximum of 3 times a day orally.
The maximum dose in 24 hours is 0.5 mg/kg body weight.
Dosing Table:
Age | Body weight | Dose | Frequency |
1-3 years | 10-14 kg | 1 mg | Up to 3 times a day |
3-5 years | 15-19 kg | 2 mg | Up to 3 times a day |
5-9 years | 20-29 kg | 2.5 mg | Up to 3 times a day |
9-18 years | 30-60 kg | 5 mg | Up to 3 times a day |
15-18 years | Over 60 kg | 10 mg | Up to 3 times a day |
Instructions for use
Do not take this medicine for more than 5 days to prevent delayed nausea and vomiting that may occur after chemotherapy.
Metoclopramide Accord is not suitable for use in children who weigh less than 30 kg. It may be more suitable for the administration of other pharmaceutical forms/concentrations for this population.
Method of administration
Swallow the tablet with a glass of water.
You should wait at least 6 hours between each dose of metoclopramide, even in case of vomiting and rejection of the dose, to avoid overdose.
Elderly population
The dose may need to be reduced depending on kidney problems, liver problems and general health problems.
Adults with kidney problems
Tell your doctor if you have kidney problems. The dose should be reduced if you have moderate or severe kidney problems.
Adults with liver problems
Tell your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.
Children and adolescents
Metoclopramide should not be used in children under 1 year of age (see section 2).
If you take more Metoclopramide Accord than you should
Contact your doctor or pharmacist immediately. You may experience uncontrollable movements (extrapyramidal disorders), feel drowsy, have some problems with consciousness, be confused, have hallucinations and heart problems. Your doctor may prescribe a treatment for these effects if necessary.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Metoclopramide Accord
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this product, ask your doctor, nurse or pharmacist.
Like all medicines, Metoclopramide Accord can cause side effects, although not everybody gets them.
Stop the treatment and inform your doctor, pharmacist immediately if you experience one of the following side effects while taking this medicine:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(frequency cannot be estimated from the available data)
Reporting of side effects:If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website, https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
..
Keep this medicine out of the sight and reach of children
Composition of Metoclopramide Accord
The name of your medicine is Metoclopramide Accord, and the active substance is metoclopramide hydrochloride. Each tablet contains 10 mg of metoclopramide hydrochloride.
The tablets contain the following non-active ingredients:
Lactose monohydrate, pregelatinised maize starch, maize starch, colloidal anhydrous silica, magnesium stearate
Appearance of the product and pack contents
White or almost white, round, biconvex tablets with "BD" engraved on one face and a score line on the other face.
The tablets can be divided into two equal halves.
The tablets are packaged in blister packs of PVC/PVdC/aluminium.
The pack contains 20, 28, 30, 40, 50, 60, 84, 100 and 500 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Accord Healthcare, S.L.U.
World Trade Center
Moll de Barcelona, s/n
Edifici Est 6ª planta
08039 Barcelona
Manufacturer
Accord Healthcare Polska Sp.z o.o.,
ul. Lutomierska 50,95-200
Pabianice,
Poland
or
Accord Healthcare Single Member S.A.
64th Km National Road Athens,
Lamia, 32009,
Greece
This medicine is authorised in the Member States of the European Economic Area and the United Kingdom (Northern Ireland) under the following names:
Member State | Medicine name |
Cyprus | Metoclopramide Accord 10 mg tablets |
Spain | Metoclopramida Accord 10 mg tablets EFG |
Italy | Metoclopramide Accord |
Netherlands | Metoclopramidemonohydrochloride Accord 10 mg tablets |
United Kingdom (Northern Ireland) | Metoclopramide Hydrochloride 10 mg tablets |
Austria | Metoclopramid hydrochloride Accord 10 mg tablets |
Denmark | Metoclopramide hydrochloride Accord |
Estonia | Metoclopramide Accord |
Finland | Metoclopramide hydrochloride Accord 10 mg tablets |
Ireland | Metoclopramide hydrochloride 10 mg tablets |
Norway | Metoclopramide Accord |
Poland | Metoclopramide Accord |
Sweden | Metoclopramide hydrochloride Accord 10 mg tablets |
Date of last revision of this leaflet:July 2024
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for METOCLOPRAMIDE ACCORD 10 mg TABLETS – subject to medical assessment and local rules.